Modification of Integration Site Preferences of an HIV-1-Based Vector by Expression of a Novel Synthetic Protein
Year: 2009
Type: article
Abstract: One of the major problems associated with retroviral vectors is that the vector may randomly integrate into host cell genes and lead to the development of cancer. LEDGF/p75 protein is thought to control the process of integration site selection by HIV-1 based vectors. This study describes a novel approach wherein a synthetic LEDGF/p75 fusion protein is utilized to alter integration site selection by an HIV-1-based vector, decreasing the number of integration events that occur in genes. HIV-1-based lentiviral vectors are a promising tool for gene therapy. However, integration of a lentiviral vector into host cell genes may lead to the development of cancer. Therefore, control of integration site selection is critical to the successful outcome of gene therapy approaches that use these vectors. The discovery that integration site selection by HIV-1 and HIV-1-based vectors is controlled by the LEDGF/p75 protein has presented new opportunities to control integration site selection. In this study, we tested the hypothesis that a fusion protein containing the C-terminal HIV integrase-binding portion of LEDGF/p75, and the N-terminal chromodomain of heterochromatin protein-1α (HP1α), can target HIV-1 vector DNA outside of genes. We show that this fusion protein, termed TIHPLE, associates with the heterochromatin hallmark trimethylated Lys-9 of histone H3 (H3K9me3). Transient overexpression of TIHPLE alters integration site selection by an HIV-1-based vector and decreases the number of integration events that occur in genes. This change in integration site selection was achieved without a reduction in overall integration efficiency. Furthermore, we show that TIHPLE increases integration in the vicinity of H3K9me3 and in repetitive DNA sequences. These data provide a novel approach to address the problem of the tendency of retroviral vectors to integrate at undesirable sites of the human genome.
Source: Human Gene Therapy
DOI: 10.1089/hum.2009.134
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2022269865
